RESEARCH & TREATMENT: Researchers find an experimental drug for liver cancer and Dasatinib, approved for chronic myeloid leukemia, act upon some Alzheimer’s disease related proteins
OLD-NEW DRUG RESEARCH: The diuretic bumetanide, used for more than 30 years to treat hypertension and heart failure, was also found to reverse signs of
RESEARCH: Worms in the lab lose their wiggle when they have Alzheimer’s. But researchers found the Vitamin B12-deficient worms kept their wiggle when the deficit
RESEARCH: Researchers say that a drug commonly used to treat cancer can restore memory and cognitive function in mice with symptoms of Alzheimer’s. Learn more.
VIDEO + ARTICLE: A study at UC San Francisco has found the odds of cognitive impairment are substantially higher for people with elevated depressive symptoms
RISK ASSESSMENT VIDEO + ARTICLE: A substantial proportion of brain changes might be due to risk factors that can be modified, according to a study
Having trouble sleeping? You’re not alone. But a group of federal agencies have provided new resources to help. Learn more.
BREAKTHROUGH: The US Food and Drug Administration (FDA) has granted a “Breakthrough Therapy” designation for donanemab, a potential new treatment for people with early symptomatic
BREAKTHROUGH & TREATMENT: The new Alzheimer’s drug aducanumabab (Aduhelm) has received accelerated approval by the US Food and Drug Administration. Why did it take so
RESEARCH: Scientists are using gold nanoparticles to create new images of the amyloid fibrils associated with Alzheimer’s disease and other neurodegenerative disorders. The fibrils are
CUTTING-EDGE VIDEO + ARTICLE: See Dr. Anthony Fitzpatrick use world-class cryo-electron microscopes to reveal molecular secrets leading to a cure for Alzheimer’s.
UPLIFTING VIDEO: Peter Berry & his Alzheimer’s are cycling 350 miles to show it’s still possible to live well with dementia.
Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
